Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma. (Record no. 24394570)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01921 a2200517 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517003948.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201504s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1549-4713 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.ophtha.2014.09.021 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tse, Brian C |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150414 |
245 00 - TITLE STATEMENT | |
Title | Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Ophthalmology |
Date of publication, distribution, etc. | Feb 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 435-7 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S. |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents, Alkylating |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Atrophy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemotherapy, Cancer, Regional Perfusion |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Choroid |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Choroid Diseases |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Combined Modality Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diseases in Twins |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enophthalmos |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorescein Angiography |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Laser Coagulation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Magnetic Resonance Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melphalan |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ophthalmic Artery |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retinal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retinoblastoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Scleritis |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Topoisomerase I Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Topotecan |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Twins, Monozygotic |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaste, Sue C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brennan, Rachel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Orr, Brent |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wilson, Matthew W |
773 0# - HOST ITEM ENTRY | |
Title | Ophthalmology |
Related parts | vol. 122 |
-- | no. 2 |
-- | p. 435-7 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ophtha.2014.09.021">https://doi.org/10.1016/j.ophtha.2014.09.021</a> |
Public note | Available from publisher's website |
No items available.